Rochester, NY — June 8, 2026 — Resiliélle®, an international leader in regenerative aesthetics and the world’s leading manufacturer of Certified Age Zero™ Exosomes, today announced that Synergy Aesthetics will serve as the exclusive representative for the Age Zero™ Exosome platform throughout a ten-state Midwest territory including Arkansas, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, Oklahoma, South Dakota, and Wisconsin.
Under the agreement, Synergy Aesthetics will introduce and sell the Age Zero™ Exosome platform across the Midwest, supporting providers with training, clinical education, hands-on practice support, and strategic implementation resources.
The partnership marks a significant milestone in Resiliélle’s continued national expansion strategy and reinforces the company’s commitment to delivering scientifically validated regenerative technologies to leading aesthetic providers across the United States.
Age Zero™ Exosomes by Resiliélle are widely recognized as the aesthetic industry’s “Gold Standard” extracellular vesicle technology — advanced, biologically active regenerative signaling particles engineered to support skin revitalization, accelerated recovery, hair restoration, and enhanced aesthetic outcomes.
The platform has undergone independent validation through the Harvard Medical School Electron Microscopy Core Facilities, confirming exceptional purity, intact lipid bilayer membrane integrity, and comprehensive characterization standards that distinguish Age Zero™ Exosomes within the rapidly expanding regenerative aesthetics market.
Designed for seamless integration into leading aesthetic procedures, Age Zero™ Exosomes are utilized alongside procedures including microneedling, laser resurfacing, RF treatments, dermaplaning, PRP protocols, and advanced hair rejuvenation therapies.
“This partnership represents an important strategic expansion for Resiliélle and reflects our commitment to aligning with organizations that share our vision for scientific integrity, provider education, and clinical excellence,” said Michael Crowley, JD, Co-Founder and Co-Managing Member of The Crowley Center for Regenerative Biotherapeutics, LLC and Resiliélle®. “Synergy Aesthetics has built an outstanding reputation for supporting aesthetic practices with innovation and professionalism, making them an ideal partner to accelerate the adoption of Certified Age Zero™ Exosomes throughout the Midwest.”
“At Resiliélle, we believe regenerative aesthetics must be grounded in science, transparency, and measurable clinical value,” added Erin Crowley, Co-Founder and Co-Managing Member of The Crowley Center for Regenerative Biotherapeutics, LLC and Resiliélle®. “This collaboration allows us to expand access to our Age Zero™ platform while ensuring providers receive the education, operational support, and strategic guidance necessary to succeed in the rapidly evolving regenerative aesthetics marketplace.”
Through this partnership, Synergy Aesthetics will provide its network of medical aesthetics practices with access to Age Zero™ Exosomes, along with the clinical education, business strategy, and implementation frameworks needed to successfully integrate regenerative technologies into their offerings.
“Resiliélle’s Age Zero™ Exosome platform represents a highly validated regenerative technology that aligns with where the industry is going,” said Brendan Sheil, Co-Founder & President of Synergy Aesthetics. “We’re excited to bring this advanced technology to our provider network and help practices implement it with structure and measurable impact.”
By combining Resiliélle’s advanced regenerative biotherapeutics platform with Synergy’s established regional infrastructure, the partnership represents a meaningful step forward in expanding access to next-generation aesthetic solutions, empowering providers while elevating patient outcomes.
About Resiliélle®
Resiliélle® is a global regenerative aesthetics company built on nanotechnology, cellular signaling, and one of the world’s largest Certified Age Zero™ exosome platforms. Headquartered in Rochester, New York, Resiliélle® leads data-driven exosome science for skin and hair, supported by clinical studies, provider experience, and large-scale protocol research.
Resiliélle® operates under The Crowley Center for Regenerative Biotherapeutics, LLC, a strategic regenerative platform founded by Michael Crowley, JD, and his daughter, Erin Crowley, whose quality engineering background helped shape the company’s validation-driven approach. Resiliélle® products are currently available for cosmetic use in the United States and select international markets, with continued global expansion underway. As a testament to its quality and following extensive supplier vetting, Resiliélle® was selected as the only approved exosome supplier for Forefront Dermatology.
For more information, visit www.SynergyAesthetics.com | www.Resilielle.com.
About Synergy Aesthetics
Synergy Aesthetics is a Midwest-based aesthetics company supporting manufacturer market access and the growth of medical aesthetics practices across ten states. Synergy partners with leading brands to scale products through disciplined regional execution while helping practices grow through operational systems, financial insight, and strategic accountability.
Media Contacts
Michael Crowley, JD
Resiliélle®
(585) 484-0058
info@resilielle.com
www.Resilielle.com
Synergy Aesthetics
info@synergyaesthetics.com
www.SynergyAesthetics.com